CLA-2-29:S:N:N7:238 810323
Mr. Joseph J. Chivini
Austin Chemical Company, Inc.
1565 Barclay Boulevard
Buffalo Grove, IL 60089-4537
RE: The tariff classification of Cysteamine hydrochloride (CAS-
156-57-0), in bulk form, from England
Dear Mr. Chivini:
In your letter dated February 23, 1995, resubmitted on April
26, 1995, you requested a tariff classification ruling.
You indicate that the subject product, Cysteamine
hydrochloride ("Mercaptamine" is "INN"), will be used in the
manufacture of hair care products, and as a pharmaceutical
intermediate. We note that Cysteamine hydrochloride is
therapeutically categorized in the USAN and the USP dictionary of
drug names (1995 edition) as an anti-urolithic (cystine calculi)
drug. We further note that The Merck Index (Eleventh Edition)
indicates that the subject product is used as an antidote to
acetaminophen, (experimentally) as a radioprotective agent, and
as a duodenal ulcerogen in rats, while Hawley's Condensed
Chemical Dictionary (Twelfth Edition) cites Cysteamine
hydrochloride's use in "Medicine (believed to offer protection
against radiation)."
The applicable subheading for Cysteamine hydrochloride, in
bulk form, will be 2930.90.9035, Harmonized Tariff Schedule of
the United States (HTS), which provides for: "Organo-sulfur
compounds: Other: Other: Other: Other: Other: Other: Drugs."
Pursuant to General Note 13, HTSUSA, the rate of duty will be
free.
This ruling is being issued under the provisions of Section
177 of the Customs Regulations (19 C.F.R. 177).
This merchandise may be subject to the regulations of the
Food and Drug Administration. You may contact them at 5600
Fishers Lane, Rockville, Maryland 20857, telephone number (301)
443-6553.
A copy of this ruling letter should be attached to the entry
documents filed at the time this merchandise is imported. If the
documents have been filed without a copy, this ruling should be
brought to the attention of the Customs officer handling the
transaction.
Sincerely,
Jean F. Maguire
Area Director
New York Seaport